Recent Articles

January 6, 2016 9:15 am
Dr. Paul Ko Ferrigno, Chief Scientific Officer, and Dr. Jane McLeod, of Avacta Life Sciences
In the current genomic era of very accurate DNA analyses by in situ hybridization, DNA chip analyses, and deep sequencing, it is often assumed that antibodies have an analogous ability to identify molecular targets accurately. Nothing could be further from the truth. Read more...
December 31, 2015 2:07 pm
Ryan Bushey, Associate Editor
Treatments for systemic sclerosis differ based on patient needs since the symptoms also vary. Read more...
December 30, 2015 10:40 am
Ryan Bushey, Associate Editor
A new report from research and consulting firm GlobalData forecasts exponential growth for the gastric cancer treatment market by 2024. Read more...
December 30, 2015 10:48 am
Ryan Bushey, Associate Editor
The market for both hemophilia A and B recombinant therapies is expected to see narrow growth by 2024. Read more...
December 21, 2015 9:50 am
Mary M. Murphy, Ph.D., Applications Scientist, Reichert Technologies
Surface Plasmon Resonance (SPR) provides important information about how biomolecules interact. Information on association and dissociation kinetics and affinity can be obtained directly in real-time and label-free. Read more...
Subscribe to Drug Discovery & Development